Skip to main content
. 2010 Dec 1;17(7-8):905–914. doi: 10.1089/ten.tea.2010.0275

FIG. 5.

FIG. 5.

Vessel diameter quantification in tissue constructs containing (A) HUVECs only, (B) MSCs only, or (C) HUVECs+MSCs in 5 (O), 10 (•), and 15 mg/mL (□) fibrin gels. In panel (A), graphic file with name inl-1.jpg indicates a statistically significant difference (p < 0.05) between 5 mg/mL fibrin (O) and 15 mg/mL fibrin (□) conditions at day 21; in panel (C), graphic file with name inl-1.jpg indicates a statistically significant difference (p < 0.05) between the 5 mg/mL condition (O) and the other two concentrations at day 21. The same data are also represented for (D) 5 mg/mL fibrin, (E) 10 mg/mL fibrin, (F) 15 mg/mL fibrin as a function of the cellular conditions, with HUVECs alone (O), MSCs alone (•), or HUVECs+MSCs (□) at days 3, 7, and 21. In panel (D), graphic file with name inl-1.jpg indicates a statistically significant difference (p < 0.05) between HUVECs+MSCs (□) and the other two conditions at day 21. Representative images on day 21 of capillary vessels formed by codelivery of HUVECs+MSCs in (G) 5, (H) 10, and (I) 15 mg/mL fibrin. Color images available online at www.liebertonline.com/tea.